Last reviewed · How we verify
intravenous injection of labeled cRBC — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
intravenous injection of labeled cRBC (intravenous injection of labeled cRBC) — Etablissement Français du Sang.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| intravenous injection of labeled cRBC TARGET | intravenous injection of labeled cRBC | Etablissement Français du Sang | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- intravenous injection of labeled cRBC CI watch — RSS
- intravenous injection of labeled cRBC CI watch — Atom
- intravenous injection of labeled cRBC CI watch — JSON
- intravenous injection of labeled cRBC alone — RSS
Cite this brief
Drug Landscape (2026). intravenous injection of labeled cRBC — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-injection-of-labeled-crbc. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab